Alterity Therapeutics Limited | PRAN - Ebit


Alterity Therapeutics Limited reported AUD-7.77M in EBIT for its fiscal semester ending in June of 2023.





Ebit Change Date
Alterity Therapeutics Limited AUD -7.77M 2.99M Jun/2023
Arca Biopharma USD -34.43M 326K Dec/2025
aTyr Pharma USD 24.47M 24.7M Dec/2025
Bio Path USD -488K 4.07M Sep/2025
Brainstorm Cell Therapeutics USD -2.05M 526K Sep/2025
Capricor Therapeutics USD -29.16M 2.87M Dec/2025
Cara Therapeutics USD -2.39M 3.16M Mar/2025
CSL USD 2.64B 116M Dec/2025
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Immunic USD -22.81M 756K Jun/2024
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Insmed USD -249.71M 11.64M Dec/2025
Minerva Neurosciences USD -4.37M 1.71M Sep/2024
TherapeuticsMD USD -1.77M 699K Sep/2023